Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Alzheimer'S Disease : JAD|October 18, 2024
Positron Emission Tomography/Computed Tomography Imaging in Therapeutic Clinical Trials in Alzheimer's Disease: An Overview of the Current State of the Art of ResearchElizabeth Katherine Anna Triumbari, Agostino Chiaravalloti, Orazio Schillaci, et al.
Cancers|July 27, 2022
Clinical Applications of Immuno-PET in Lymphoma: A Systematic ReviewElizabeth Katherine Anna Triumbari, David Morland, Riccardo Laudicella, et al.
Diagnostics (Basel, Switzerland)|October 27, 2022
Classical Hodgkin Lymphoma: A Joint Clinical and PET Model to Predict Poor Responders at Interim AssessmentElizabeth Katherine Anna Triumbari, David Morland, Annarosa Cuccaro, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Radiomics in Oncological PET Imaging: A Systematic Review-Part 1, Supradiaphragmatic CancersDavid Morland, Elizabeth Katherine Anna Triumbari, Luca Boldrini, et al.
Diagnostics (Basel, Switzerland)|June 24, 2022
Radiomics in Oncological PET Imaging: A Systematic Review-Part 2, Infradiaphragmatic Cancers, Blood Malignancies, Melanoma and Musculoskeletal CancersDavid Morland, Elizabeth Katherine Anna Triumbari, Luca Boldrini, et al.
Endocrine|October 6, 2022
Bone metastases in midgut neuroendocrine tumors: imaging characteristics, distribution, and risk factorsMaxime Lelièvre, Elizabeth Katherine Anna Triumbari, Hedia Brixi, et al.
Clinical Nuclear Medicine|May 3, 2023
Impact of Cold Somatostatin Analog Administration on Somatostatin Receptor Imaging: A Systematic ReviewDavid Morland, Nicolas Laures, Elizabeth Katherine Anna Triumbari, et al.
Frontiers in Medicine|July 11, 2022
Healthy Organs Uptake on Baseline 18F-FDG PET/CT as an Alternative to Total Metabolic Tumor Volume to Predict Event-Free Survival in Classical Hodgkin's LymphomaDavid Morland, Elizabeth Katherine Anna Triumbari, Elena Maiolo, et al.
Annals of Nuclear Medicine|May 18, 2026
Semiquantitative SSTR PET metrics show molecular-morphologic discordance after 177Lu-DOTATATE in gastroenteropancreatic neuroendocrine neoplasms: an exploratory paired target-lesion analysisAgostino Chiaravalloti, Martina Egidi, Antonio D'Agostini, et al.
Medicine|January 10, 2023
Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot studyDavid Morland, Elizabeth Katherine Anna Triumbari, Christopher Hoog, et al.
Pageof 3